Achaogen, Inc. (AKAO) financial statements (2020 and earlier)

Company profile

Business Address 1 TOWER PLACE
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3158101144165199230
Cash and cash equivalents31566395145135144
Short-term investments 33749206586
Other undisclosed cash, cash equivalents, and short-term investments0(0)(0)00(0)0
Restricted cash and investments25067679
Inventory, net of allowances, customer advances and progress billings11     
Inventory11     
Prepaid expense1222212
Assets held-for-sale, not part of disposal group2      
Other current assets0011000
Other undisclosed current assets2688657
Total current assets:6168117162178213248
Noncurrent Assets
Inventory, Noncurrent92     
Property, plant and equipment2162117151311
Restricted cash and investments1611444
Other noncurrent assets9643   
Total noncurrent assets:21302621191715
TOTAL ASSETS:8297143183197230263
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28253022221516
Accounts payable121177768
Accrued liabilities151424151598
Debt50   131310
Derivative instruments and hedges, liabilities11     
Deferred revenue and credits2233
Other liabilities      0
Other undisclosed current liabilities 01    
Total current liabilities:78273123373030
Noncurrent Liabilities
Long-term debt and lease obligation 25252491215
Long-term debt, excluding current maturities 25252491215
Liabilities, other than long-term debt1091110987
Deferred revenue and credits9886
Deferred rent credit10910 
Derivative instruments and hedges, liabilities  11111
Other undisclosed noncurrent liabilities03712101623
Total noncurrent liabilities:10364347283645
Total liabilities:89637470656775
Stockholders' equity
Stockholders' equity attributable to parent(6)2559103122153179
Common stock0000000
Additional paid in capital553537529523495490485
Accumulated other comprehensive loss  (0)(0) (0)(0)
Accumulated deficit(559)(512)(470)(420)(373)(336)(307)
Other undisclosed stockholders' equity 10101010  
Total stockholders' equity:(6)3569113132153179
TOTAL LIABILITIES AND EQUITY:8297143183197220253

Income statement (P&L) ($ in millions)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
Revenues2232211
Revenue, net 00
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)     
Gross profit:2232211
Operating expenses(46)(49)(57)(46)(44)(37)(31)
Other undisclosed operating income00     
Operating loss:(44)(47)(55)(44)(42)(37)(30)
Nonoperating income
(Other Nonoperating income)
0011110
Interest and debt expense(1)(0)(0)(1)(1)(1)(1)
Loss before gain (loss) on sale of properties:(44)(47)(55)(45)(42)(37)(30)
Other undisclosed net loss(3)      
Net loss:(48)(47)(55)(45)(42)(37)(30)
Other undisclosed net income (loss) attributable to parent 55(3)674
Net loss available to common stockholders, basic:(48)(42)(50)(47)(36)(30)(26)
Other undisclosed net loss available to common stockholders, diluted(2)(5)(5)  (7)(4)
Net loss available to common stockholders, diluted:(50)(47)(55)(47)(36)(37)(30)

Comprehensive Income ($ in millions)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
Net loss:(48)(47)(55)(45)(42)(37)(30)
Comprehensive loss:(48)(47)(55)(45)(42)(37)(30)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 55(3)674
Comprehensive loss, net of tax, attributable to parent:(48)(42)(50)(47)(36)(30)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: